Oslo universitetssykehus, Radiumhospitalet ( Site 2400)

Oslo 0424

1 studies enrolling now · 2 studies all time

What they study most

Advanced Gastrointestinal Stromal Tumor, Carcinoma, Squamous Cell, HIF-2α Mutated Cancers, Pancreatic Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma, Skin Neoplasms, Von Hippel-Lindau Disease

Studies at this site

• Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) — Recruiting now
• A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007) — Stopped early